Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | NVCN |
---|---|---|
09:32 ET | 100 | 29.41 |
09:34 ET | 1100 | 29.41 |
09:59 ET | 100 | 29.43 |
10:14 ET | 140 | 29.6176 |
10:32 ET | 100 | 29.48 |
10:35 ET | 591 | 29.5 |
10:37 ET | 628 | 29.5 |
10:42 ET | 800 | 29.41 |
10:44 ET | 100 | 29.41 |
10:48 ET | 100 | 29.43 |
10:50 ET | 200 | 29.41 |
11:00 ET | 1413 | 29.41 |
11:06 ET | 253 | 29.4479 |
11:09 ET | 2200 | 29.41 |
11:11 ET | 100 | 29.4454 |
11:27 ET | 100 | 29.45 |
11:45 ET | 100 | 29.41 |
11:58 ET | 100 | 29.45 |
12:14 ET | 200 | 29.41 |
12:41 ET | 8260 | 29.52 |
12:48 ET | 292 | 29.58 |
01:15 ET | 100 | 29.62 |
01:21 ET | 300 | 29.57 |
01:48 ET | 100 | 29.6 |
02:04 ET | 200 | 29.6 |
02:24 ET | 500 | 29.6 |
02:27 ET | 200 | 29.5 |
02:56 ET | 100 | 29.58 |
03:18 ET | 1616 | 29.6 |
03:32 ET | 600 | 29.6 |
03:54 ET | 10000 | 29.61 |
03:57 ET | 9735 | 29.79 |
03:59 ET | 445 | 29.88 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Neovasc Inc | 111.2M | 0.0x | --- |
Neovasc Inc. is a Canada-based specialty medical device company. The Company develops, manufactures, and markets products for the cardiovascular marketplace. The Company is engaged in the development of minimally invasive therapies in cardiovascular care: refractory angina and mitral valve regurgitation. Its products include the Neovasc Reducer (Reducer), for the treatment of refractory angina, and the Tiara (Tiara), for the transcatheter treatment of mitral valve disease, which is currently under clinical investigation in the United States, Canada, Israel and Europe. The Company operates through one business segment: the development, manufacturing and marketing of medical devices. The Company's subsidiaries include Neovasc Medical Inc., Neovasc Tiara Inc., Neovasc (US) Inc., Neovasc Medical Ltd., B-Balloon Ltd., Neovasc GmbH, and Neovasc Management Inc. The Company carries its business in Canada, the United States and Europe.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $111.2M |
---|---|
Revenue (TTM) | $4.3M |
Shares Outstanding | 2.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.92 |
EPS | $-16.87 |
Book Value | $26.47 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 26.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -857.91% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.